On January 5, 2018, the Maryland Health Care Commission (MHCC) released a request for proposals (RFP MHCC 18-012) seeking applicants to implement and test innovative telehealth service delivery for opioid addiction treatment. The goal is to optimize medication assisted treatment (MAT) with buprenorphine, and to expand treatment services in underserved areas of Maryland. Maximum state funding for the project is $150,000, and the applicants must be prepared to provide a 1:1 match. The MHCC intends to select a single applicant for a grant of up to $150,000, but reserves the option to award smaller grants to . . .